American Vanguard Corporation (AVD) Aandelenanalyse

Bedrijfsoverzicht

American Vanguard Corporation is a specialized developer, manufacturer, and marketer of synthetic, biological, and biorational products designed for agricultural, commercial, and consumer applications within the United States and international markets. The company operates within the Basic Materials sector, specifically focusing on the Agricultural Inputs industry, which positions it as a critical supplier of essential chemical and biological solutions for crop production and soil management. The firm employs 739 individuals and holds a market capitalization of $66.50M, while reporting trailing twelve-month (TTM) revenue of $515.11M. These financial metrics indicate that the company functions as a small-cap entity with significant operational scale relative to its valuation, suggesting a business model that generates substantial top-line sales despite its modest market equity. The disparity between its $515.11M in annual revenue and its $66.50M market cap highlights a market assessment that heavily weighs the company's current profitability challenges rather than its underlying revenue generation capabilities.

Financiële gezondheid

The company's financial statements for the trailing twelve months reveal a revenue of $515.11M paired with a net income of -$49,882,000 and an EBITDA of $22.80M. The substantial gap between the $515.11M revenue and the negative net income underscores a cost structure where operating expenses and interest charges exceed earnings before interest and taxes, resulting in a pre-tax loss that impacts the bottom line significantly. Free cash flow stands at -$4,736,875, indicating that the company is currently burning cash rather than generating liquidity from its core operations, which constrains financial flexibility and reliance on external capital sources. Profitability is further contextualized by a gross margin of 28.6%, an operating margin of 3.5%, and a negative profit margin of -9.7%, illustrating that while production costs are managed to nearly 71.4% of sales, operational overheads and other expenses erode earnings to a negative level. On the balance sheet, the company holds $12.43M in cash against $191.39M in debt, resulting in a debt-to-equity ratio of 99.47, which signifies a highly leveraged position where interest obligations are substantial relative to shareholder equity. Liquidity management is supported by a current ratio of 1.77, suggesting that the company possesses sufficient current assets to cover its short-term liabilities with a margin of safety above the 1.0 threshold. Return on equity is recorded at -23.4% and return on assets at 0.4%, metrics that reveal management's current ineffectiveness in generating returns on the capital invested by shareholders and the asset base, respectively.

Waarderingsbeoordeling

Valuation metrics present a complex picture with a trailing P/E ratio of N/A due to negative earnings, while the forward P/E is 5.97, implying that the market is pricing in a significant turnaround or expected earnings recovery in the coming fiscal periods. The price-to-book ratio stands at 0.35, indicating that the stock is trading at a significant discount to its net asset value, which often suggests the market undervalues the company's tangible assets or anticipates further value destruction. Alternative valuation measures such as a price-to-sales ratio of 0.13 and an EV/EBITDA of 10.77 provide context, showing that the company is valued very cheaply relative to its sales volume but maintains a multiple that is elevated compared to the price-to-book figure when earnings are normalized. The stock price has fluctuated between a 52-week high of $5.92 and a 52-week low of $2.05, and assuming a current price near the lower end of this range, the security trades at a discount relative to its recent peak, reflecting ongoing investor caution regarding its financial stability. The beta value of 1.43 indicates that the stock exhibits higher volatility than the broader market, moving approximately 43% more aggressively than the benchmark index during periods of market turbulence.

Growth & Income

Growth dynamics are characterized by a revenue decline of -9.0% year-over-year, while earnings growth is listed as N/A due to the company's recent losses. The contraction in revenue combined with negative earnings growth implies that the business is facing headwinds that affect both its top-line sales and its ability to generate profitability simultaneously. As a non-dividend payer with a dividend yield of N/A and a payout ratio of 0.0%, the company does not distribute income to shareholders and instead retains its limited cash flow to fund operations or pay down debt. Consequently, the overall growth and income profile for American Vanguard Corporation is defined by a lack of dividend income and a recent period of revenue contraction, requiring stakeholders to rely on potential future earnings recovery rather than current cash distributions or capital appreciation from a growing payout.